{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:42:32Z","timestamp":1774636952116,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,17]]},"DOI":"10.7759\/cureus.41994","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T09:44:48Z","timestamp":1689587088000},"source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of Omeprazole in Acid Peptic Disease: A Real-World, Patient-Reported Outcome Measures Study"],"prefix":"10.7759","author":[{"given":"Suresh","family":"Jain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Shamrao Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyoti R","family":"Mahapatra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip","family":"Todi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anup U","family":"Petare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritwik","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Rathod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amey","family":"Mane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gauri","family":"Dhanaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhavesh P","family":"Kotak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-016-1166-4","article-title":"Evidence-based clinical practice guidelines for peptic ulcer disease 2015","volume":"51","author":"Satoh K","year":"2016","unstructured":"Satoh K, Yoshino J, Akamatsu T, et al.. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol. 2016, 51:177-94. 10.1007\/s00535-016-1166-4","journal-title":"J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2018.06.003","article-title":"Acid peptic disease","volume":"98","author":"Kempenich JW","year":"2018","unstructured":"Kempenich JW, Sirinek KR. Acid peptic disease. Surg Clin North Am. 2018, 98:933-44. 10.1016\/j.suc.2018.06.003","journal-title":"Surg Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2016.1142872","article-title":"Management of NSAID-associated peptic ulcer disease","volume":"10","author":"Melcarne L","year":"2016","unstructured":"Melcarne L, Garc\u00eda-Iglesias P, Calvet X. Management of NSAID-associated peptic ulcer disease. Expert Rev Gastroenterol Hepatol. 2016, 10:723-33. 10.1586\/17474124.2016.1142872","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199506001-00002","article-title":"Suppression of acid secretion in peptic ulcer disease","volume":"20","author":"Feldman M","year":"1995","unstructured":"Feldman M. Suppression of acid secretion in peptic ulcer disease. J Clin Gastroenterol. 1995, 20:S1-6. 10.1097\/00004836-199506001-00002","journal-title":"J Clin Gastroenterol"},{"key":"ref5","article-title":"Reliving 25 years of experience with omeprazole in acid-peptic diseases","volume":"66","author":"Sharma P","year":"2018","unstructured":"Sharma P. Reliving 25 years of experience with omeprazole in acid-peptic diseases. J Assoc Physicians India. 2018, 66:72-8.","journal-title":"J Assoc Physicians India"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/00365528909091311","article-title":"Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study","volume":"167","author":"Unge P","year":"1989","unstructured":"Unge P, Gad A, Gnarpe H, Olsson J. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study. Scand J Gastroenterol Suppl. 1989, 167:49-54. 10.3109\/00365528909091311","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00527.x","article-title":"Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial","volume":"13","author":"Maton PN","year":"1999","unstructured":"Maton PN, Orlando R, Joelsson B. Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial. Aliment Pharmacol Ther. 1999, 13:819-26. 10.1046\/j.1365-2036.1999.00527.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14331","article-title":"Standardized system and app for continuous patient symptom logging in gastroduodenal disorders: design, implementation, and validation","volume":"34","author":"Sebaratnam G","year":"2022","unstructured":"Sebaratnam G, Karulkar N, Calder S, et al.. Standardized system and app for continuous patient symptom logging in gastroduodenal disorders: design, implementation, and validation. Neurogastroenterol Motil. 2022, 34:e14331. 10.1111\/nmo.14331","journal-title":"Neurogastroenterol Motil"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson MJ","year":"2004","unstructured":"Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes. 2004, 2:12. 10.1186\/1477-7525-2-12","journal-title":"Health Qual Life Outcomes"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20211945","article-title":"Effect of omeprazole on patient-reported outcome measures in uninvestigated heartburn: a multi-country, multi-center observational study","volume":"9","author":"Lazebnik LB","year":"2021","unstructured":"Lazebnik LB, Alekseenko SA, Tkach SM, et al.. Effect of omeprazole on patient-reported outcome measures in uninvestigated heartburn: a multi-country, multi-center observational study. Int J Res Med Sci. 2021, 9:1587-97. 10.18203\/2320-6012.ijrms20211945","journal-title":"Int J Res Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02306.x","article-title":"Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial","volume":"95","author":"Meineche-Schmidt V","year":"2000","unstructured":"Meineche-Schmidt V, Christensen E. Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial. Am J Gastroenterol. 2000, 95:2777-83. 10.1111\/j.1572-0241.2000.02306.x","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00410.x","article-title":"Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies)","volume":"12","author":"Talley NJ","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Par\u00e9 P, et al.. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther. 1998, 12:1055-65. 10.1046\/j.1365-2036.1998.00410.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80032-6","article-title":"The proton-pump inhibitors: similarities and differences","volume":"22","author":"Horn J","year":"2000","unstructured":"Horn J. The proton-pump inhibitors: similarities and differences. Clin Ther. 2000, 22:266-80. 10.1016\/S0149-2918(00)80032-6","journal-title":"Clin Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1540\/jsmr.47.79","article-title":"The effect of omeprazole on gastric myoelectrical activity and emptying","volume":"47","author":"Kamiya T","year":"2011","unstructured":"Kamiya T, Shikano M, Tanaka M, et al.. The effect of omeprazole on gastric myoelectrical activity and emptying. J Smooth Muscle Res. 2011, 47:79-87. 10.1540\/jsmr.47.79","journal-title":"J Smooth Muscle Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(01)80018-7","article-title":"A review of omeprazole use in the treatment of acid-related disorders in children","volume":"23","author":"Zimmermann AE","year":"2001","unstructured":"Zimmermann AE, Walters JK, Katona BG, Souney PE, Levine D. A review of omeprazole use in the treatment of acid-related disorders in children. Clin Ther. 2001, 23:660-79. 10.1016\/s0149-2918(01)80018-7","journal-title":"Clin Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_378.x","article-title":"Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas","volume":"98","author":"Jensen RT","year":"2006","unstructured":"Jensen RT. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol. 2006, 98:4-19. 10.1111\/j.1742-7843.2006.pto_378.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.04871.x","article-title":"Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine","volume":"22","author":"Miyamoto M","year":"2007","unstructured":"Miyamoto M, Haruma K, Kuwabara M, Nagano M, Okamoto T, Tanaka M. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine. J Gastroenterol Hepatol. 2007, 22:639-44. 10.1111\/j.1440-1746.2007.04871.x","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/165340-effectiveness-of-omeprazole-in-acid-peptic-disease-a-real-world-patient-reported-outcome-measures-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:16Z","timestamp":1707509116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/165340-effectiveness-of-omeprazole-in-acid-peptic-disease-a-real-world-patient-reported-outcome-measures-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.41994","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}